Tupchong K, Koyfman A and Foran M: Sepsis, severe sepsis, and septic shock: A review of the literature. Afr J Emerg Med. 5:127–135. 2015. View Article : Google Scholar

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, et al: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 49:e1063–e1143. 2021. View Article : Google Scholar : PubMed/NCBI

Matthaeus-Kraemer CT, Thomas-Rueddel DO, Schwarzkopf D, Rueddel H, Poidinger B, Reinhart K and Bloos F: Crossing the handover chasm: Clinicians' perceptions of barriers to the early detection and timely management of severe sepsis and septic shock. J Crit Care. 36:85–91. 2016. View Article : Google Scholar : PubMed/NCBI

Liu Y, Xu L, Yang Z, Wang D, Li T, Yang F, Li Z, Bai X and Wang Y: Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota. Biomed Pharmacother. 163:1148372023. View Article : Google Scholar : PubMed/NCBI

Mankowski RT, Laitano O, Clanton TL and Brakenridge SC: Pathophysiology and treatment strategies of acute myopathy and muscle wasting after sepsis. J Clin Med. 10:18742021. View Article : Google Scholar : PubMed/NCBI

Callahan LA and Supinski GS: Sepsis-induced myopathy. Crit Care Med. 37(10 Suppl): S354–S367. 2009. View Article : Google Scholar

Schefold JC, Bierbrauer J and Weber-Carstens S: Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 1:147–157. 2010. View Article : Google Scholar

Liu W, Hu C and Zhao S: Sarcopenia and mortality risk of patients with sepsis: A meta-analysis. Int J Clin Pract. 2022:49744102022. View Article : Google Scholar : PubMed/NCBI

Panahi A, Malekmohammad M, Soleymani F and Hashemian SM: The prevalence and outcome of intensive care unit acquired weakness (ICUAW). Tanaffos. 19:250–255. 2020.

Dinglas VD, Aronson Friedman L, Colantuoni E, Mendez-Tellez PA, Shanholtz CB, Ciesla ND, Pronovost PJ and Needham DM: Muscle weakness and 5-year survival in acute respiratory distress syndrome survivors. Crit Care Med. 45:446–453. 2017. View Article : Google Scholar : PubMed/NCBI

Meyer-Frießem CH, Malewicz NM, Rath S, Ebel M, Kaisler M, Tegenthoff M, Schildhauer TA, Pogatzki-Zahn EM, Maier C and Zahn PK: Incidence, time course and influence on quality of life of intensive care unit-acquired weakness symptoms in long-term intensive care survivors. J Intensive Care Med. 36:1313–1322. 2021. View Article : Google Scholar

Appleton RT, Kinsella J and Quasim T: The incidence of intensive care unit-acquired weakness syndromes: A systematic review. J Intensive Care Soc. 16:126–136. 2015. View Article : Google Scholar : PubMed/NCBI

de Andrade-Junior MC, de Salles ICD, de Brito CMM, Pastore-Junior L, Righetti RF and Yamaguti WP: Skeletal muscle wasting and function impairment in intensive care patients with severe COVID-19. Front Physiol. 12:6409732021. View Article : Google Scholar : PubMed/NCBI

Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, et al: Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 364:1293–1304. 2011. View Article : Google Scholar : PubMed/NCBI

Odden AJ, Rohde JM, Bonham C, Kuhn L, Malani PN, Chen LM, Flanders SA and Iwashyna TJ: Functional outcomes of general medical patients with severe sepsis. BMC Infect Dis. 13:5882013. View Article : Google Scholar : PubMed/NCBI

Zhang J, Huang Y, Chen Y, Shen X, Pan H and Yu W: Impact of muscle mass on survival in patients with sepsis: A systematic review and meta-analysis. Ann Nutr Metab. 77:330–336. 2021. View Article : Google Scholar : PubMed/NCBI

Yan W, Chen Y, Guo Y, Xia Y, Li C, Du Y, Lin C, Xu X, Qi T, Fan M, et al: Irisin promotes cardiac homing of intravenously delivered MSCs and protects against ischemic heart injury. Adv Sci (Weinh). 9:e21036972022. View Article : Google Scholar : PubMed/NCBI

Gnecchi M, Danieli P and Cervio E: Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol. 57:48–55. 2012. View Article : Google Scholar : PubMed/NCBI

Tzouvelekis A, Toonkel R, Karampitsakos T, Medapalli K, Ninou I, Aidinis V, Bouros D and Glassberg MK: Mesenchymal stem cells for the treatment of idiopathic pulmonary fibrosis. Front Med (Lausanne). 5:1422018. View Article : Google Scholar : PubMed/NCBI

Sinclair K, Yerkovich ST and Chambers DC: Mesenchymal stem cells and the lung. Respirology. 18:397–411. 2013. View Article : Google Scholar : PubMed/NCBI

Ye T, Chen Z, Zhang J, Luo L, Gao R, Gong L, Du Y, Xie Z, Zhao B, Li Q and Wang Y: Large extracellular vesicles secreted by human iPSC-derived MSCs ameliorate tendinopathy via regulating macrophage heterogeneity. Bioact Mater. 21:194–208. 2022.PubMed/NCBI

He X, Ai S, Guo W, Yang Y, Wang Z, Jiang D and Xu X: Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: Aphase 1 clinical trial. Transl Res. 199:52–61. 2018. View Article : Google Scholar : PubMed/NCBI

Cribbs SK and Martin GS: Stem cells in sepsis and acute lung injury. Am J Med Sci. 341:325–332. 2011. View Article : Google Scholar

Walter J, Ware LB and Matthay MA: Mesenchymal stem cells: Mechanisms of potential therapeutic benefit in ARDS and sepsis. Lancet Respir Med. 2:1016–1026. 2014. View Article : Google Scholar : PubMed/NCBI

Khosrojerdi A, Soudi S, Hosseini AZ, Eshghi F, Shafiee A and Hashemi SM: Immunomodulatory and therapeutic effects of mesenchymal stem cells on organ dysfunction in sepsis. Shock. 55:423–440. 2021. View Article : Google Scholar

Ho MSH, Mei SHJ and Stewart DJ: The immunomodulatory and therapeutic effects of mesenchymal stromal cells for acute lung injury and sepsis. J Cell Physiol. 230:2606–2617. 2015. View Article : Google Scholar : PubMed/NCBI

Friedenstein AJ, Petrakova KV, Kurolesova AI and Frolova GP: Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 6:230–247. 1968. View Article : Google Scholar : PubMed/NCBI

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans R, Keating A, Prockop D and Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8:315–317. 2006. View Article : Google Scholar : PubMed/NCBI

Bianco P: 'Mesenchymal' stem cells. Annu Rev Cell Dev Biol. 30:677–704. 2014. View Article : Google Scholar

Rankin S: Mesenchymal stem cells. Thorax. 67:565–566. 2012. View Article : Google Scholar : PubMed/NCBI

Jiang W and Xu J: Immune modulation by mesenchymal stem cells. Cell Prolif. 53:e127122020. View Article : Google Scholar :

Yianni V and Sharpe PT: Perivascular-derived mesenchymal stem cells. J Dent Res. 98:1066–1072. 2019. View Article : Google Scholar : PubMed/NCBI

Zimmermann JA, Hettiaratchi MH and McDevitt TC: Enhanced immunosuppression of T cells by sustained presentation of bioactive interferon-γ within three-dimensional mesenchymal stem cell constructs. Stem Cells Transl Med. 6:223–237. 2017. View Article : Google Scholar : PubMed/NCBI

Yarygin KN, Lupatov AY and Sukhikh GT: Modulation of immune responses by mesenchymal stromal cells. Bull Exp Biol Med. 161:561–565. 2016. View Article : Google Scholar : PubMed/NCBI

Glenn JD and Whartenby KA: Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells. 6:526–539. 2014. View Article : Google Scholar : PubMed/NCBI

Saeedi P, Halabian R and Fooladi AAI: Antimicrobial effects of mesenchymal stem cells primed by modified LPS on bacterial clearance in sepsis. J Cell Physiol. 234:4970–4986. 2019. View Article : Google Scholar

Spees JL, Lee RH and Gregory CA: Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther. 7:1252016. View Article : Google Scholar : PubMed/NCBI

Le Blanc K, Tammik C, Rosendahl K, Zetterberg E and Ringdén O: HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 31:890–896. 2003. View Article : Google Scholar : PubMed/NCBI

Uccelli A, Moretta L and Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol. 8:726–736. 2008. View Article : Google Scholar

Minguell JJ, Conget P and Erices A: Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res. 33:881–887. 2000. View Article : Google Scholar : PubMed/NCBI

Kim WY and Hong SB: Sepsis and acute respiratory distress syndrome: Recent update. Tuberc Respir Dis (Seoul). 79:53–57. 2016. View Article : Google Scholar : PubMed/NCBI

Martin GS and Bernard GR: Airway and lung in sepsis. Intensive Care Med. 27(Suppl 1): S63–S79. 2001. View Article : Google Scholar : PubMed/NCBI

Davis C: Risk factors for the development of acute lung injury in patients with septic shock: An observational cohort study. J Emerg Med. 36:P982009. View Article : Google Scholar

Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, et al: The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 18:1217–1223. 2012. View Article : Google Scholar : PubMed/NCBI

Lee WL and Slutsky AS: Sepsis and endothelial permeability. N Engl J Med. 363:689–691. 2010. View Article : Google Scholar : PubMed/NCBI

Lomas-Neira J, Perl M, Venet F, Chung CS and Ayala A: The role and source of tumor necrosis factor-α in hemorrhage-induced priming for septic lung injury. Shock. 37:611–620. 2012. View Article : Google Scholar : PubMed/NCBI

Wang L, Taneja R, Razavi HM, Law C, Gillis C and Mehta S: Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo. Shock. 37:539–547. 2012. View Article : Google Scholar : PubMed/NCBI

Grover SP and Mackman N: Tissue factor: An essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol. 38:709–725. 2018. View Article : Google Scholar : PubMed/NCBI

Witkowski M, Landmesser U and Rauch U: Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med. 26:297–303. 2016. View Article : Google Scholar : PubMed/NCBI

Evans CE and Zhao YY: Impact of thrombosis on pulmonary endothelial injury and repair following sepsis. Am J Physiol Lung Cell Mol Physiol. 312:L441–L451. 2017. View Article : Google Scholar : PubMed/NCBI

Zhao Y, Yang C, Wang H, Li H, Du J, Gu W and Jiang J: Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats. Int Immunopharmacol. 15:246–253. 2013. View Article : Google Scholar : PubMed/NCBI

Lee FY, Chen KH, Wallace CG, Sung PH, Sheu JJ, Chung SY, Chen YL, Lu HI, Ko SF, Sun CK, et al: Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis. Oncotarget. 8:45626–45642. 2017. View Article : Google Scholar : PubMed/NCBI

Asami T, Ishii M, Namkoong H, Yagi K, Tasaka S, Asakura T, Suzuki S, Kamo T, Okamori S, Kamata H, et al: Anti-inflammatory roles of mesenchymal stromal cells during acute Streptococcus pneumoniae pulmonary infection in mice. Cytotherapy. 20:302–313. 2017. View Article : Google Scholar

Chen HH, Chang CL, Lin KC, Sung PH, Chai HT, Zhen YY, Chen YC, Wu YC, Leu S, Tsai TH, et al: Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury. Am J Transl Res. 6:439–458. 2014.PubMed/NCBI

Li W, Chen W, Huang S, Tang X, Yao G and Sun L: Mesenchymal stem cells enhance pulmonary antimicrobial immunity and prevent following bacterial infection. Stem Cells Int. 2020:31694692020. View Article : Google Scholar : PubMed/NCBI

Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW and Matthay MA: Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells. 28:2229–2238. 2010. View Article : Google Scholar : PubMed/NCBI

Rabani R, Volchuk A, Jerkic M, Ormesher L, Garces-Ramirez L, Canton J, Masterson C, Gagnon S, Tatham KC, Marshall J, et al: Mesenchymal stem cells enhance NOX2-dependent reactive oxygen species production and bacterial killing in macrophages during sepsis. Eur Respir J. 51:17020212018. View Article : Google Scholar : PubMed/NCBI

Yao M, Cui B, Zhang W, Ma W, Zhao G and Xing L: Exosomal miR-21 secreted by IL-1β-primed-mesenchymal stem cells induces macrophage M2 polarization and ameliorates sepsis. Life Sci. 264:1186582021. View Article : Google Scholar

Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, Gupta N, Petrini M and Matthay MA: Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol. 302:L1003–L1013. 2012. View Article : Google Scholar : PubMed/NCBI

Tan L, Huang Y, Pan X, Quan S, Xu S, Li D, Song L, Zhang X, Chen W and Pan J: Administration of bone marrow stromal cells in sepsis attenuates sepsis-related coagulopathy. Ann Med. 48:235–245. 2016. View Article : Google Scholar : PubMed/NCBI

Dos Santos CC, Amatullah H, Vaswani CM, Maron-Gutierrez T, Kim M, Mei SHJ, Szaszi K, Monteiro APT, Varkouhi AK, Herreroz R, et al: Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury. Eur Respir J. 59:20042162022. View Article : Google Scholar

Younes N, Zhou L, Amatullah H, Mei SHJ, Herrero R, Lorente JA, Stewart DJ, Marsden P, Liles WC, Hu P and Dos Santos CC: Mesenchymal stromal/stem cells modulate response to experimental sepsis-induced lung injury via regulation of miR-27a-5p in recipient mice. Thorax. 75:556–567. 2020. View Article : Google Scholar : PubMed/NCBI

Bi CF, Liu J, Yang LS and Zhang JF: Research progress on the mechanism of sepsis induced myocardial injury. J Inflamm Res. 15:4275–4290. 2022. View Article : Google Scholar : PubMed/NCBI

Aneman A and Vieillard-Baron A: Cardiac dysfunction in sepsis. Intensive Care Med. 42:2073–2076. 2016. View Article : Google Scholar : PubMed/NCBI

Rudiger A and Singer M: Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 35:1599–1608. 2007. View Article : Google Scholar : PubMed/NCBI

Kumar A, Thota V, Dee L, Olson J, Uretz E and Parrillo JE: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. Resuscitation. 32:P1661996. View Article : Google Scholar

Zhang X, Lu C, Gao M, Cao X, Ha T, Kalbfleisch JH, Williams DL, Li C and Kao RL: Toll-like receptor 4 plays a central role in cardiac dysfunction during trauma hemorrhage shock. Shock. 42:31–37. 2014. View Article : Google Scholar : PubMed/NCBI

Sato R and Nasu M: A review of sepsis-induced cardiomyopathy. J Intensive Care. 3:482015. View Article : Google Scholar : PubMed/NCBI

Stengl M, Bartak F, Sykora R, Chvojka J, Benes J, Krouzecky A, Novak I, Sviglerova J, Kuncova J and Matejovic M: Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock. Crit Care Med. 38:579–587. 2010. View Article : Google Scholar

Kumar A, Brar R, Wang P, Dee L, Skorupa G, Khadour F, Schulz R and Parrillo JE: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol. 276:R265–R276. 1999.PubMed/NCBI

Lv X and Wang H: Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res. 3:302016.PubMed/NCBI

Wu Y, Zhou J, Bi L, Huang M, Han Y, Zhang Q, Zhu D and Zhou S: Effects of bone marrow mesenchymal stem cells on the cardiac function and immune system of mice with endotoxemia. Mol Med Rep. 13:5317–5325. 2016. View Article : Google Scholar : PubMed/NCBI

Weil BR, Herrmann JL, Abarbanell AM, Manukyan MC, Poynter JA and Meldrum DR: Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia. Shock. 36:235–241. 2011. View Article : Google Scholar : PubMed/NCBI

Wang X, Huang W, Wang Y and Fan GC: Abstract 12290: Exosomal miR-223 contributes to mesenchymal stem cell-elicited cardio-protection in polymicrobial sepsis. Circulation. 1322015.

Giovannini I, Chiarla C, Giuliante F, Vellone M, Ardito F and Nuzzo G: Sepsis-induced cholestasis. Hepatology. 47:3612008. View Article : Google Scholar

Woźnica EA, Inglot M, Woźnica RK and Łysenko L: Liver dysfunction in sepsis. Adv Clin Exp Med. 27:547–551. 2018. View Article : Google Scholar

Gaddam RR, Fraser R, Badiei A, Chambers S, Cogger VC, Le Couteur DG and Bhatia M: Differential effects of kupffer cell inactivation on inflammation and the liver sieve following caecal-ligation and puncture-induced sepsis in mice. Shock. 47:480–490. 2017. View Article : Google Scholar

Wang H and Liu D: Baicalin inhibits high-mobility group box 1 release and improves survival in experimental sepsis. Shock. 41:324–330. 2014. View Article : Google Scholar : PubMed/NCBI

Wang D, Yin Y and Yao Y: Advances in sepsis-associated liver dysfunction. Burns Trauma. 2:97–105. 2014. View Article : Google Scholar : PubMed/NCBI

Yagi H, Soto-Gutierrez A, Kitagawa Y, Tilles AW, Tompkins RG and Yarmush ML: Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant. 19:823–830. 2010. View Article : Google Scholar : PubMed/NCBI

Wu KH, Wu HP, Chao WR, Lo WY, Tseng PC, Lee CJ, Peng CT, Lee MS and Chao YH: Time-series expression of toll-like receptor 4 signaling in septic mice treated with mesenchymal stem cells. Shock. 45:634–640. 2016. View Article : Google Scholar

Miao CM, Jiang XW, He K, Li PZ, Liu ZJ, Cao D, Ou ZB, Gong JP, Liu CA and Cheng Y: Bone marrow stromal cells attenuate LPS-induced mouse acute liver injury via the prostaglandin E 2-dependent repression of the NLRP3 inflammasome in Kupffer cells. Immunol Lett. 179:102–113. 2016. View Article : Google Scholar : PubMed/NCBI

Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan B and Yarmush ML: Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther. 18:1857–1864. 2010. View Article : Google Scholar : PubMed/NCBI

Liang H, Ding X, Yu Y, Zhang H, Wang L, Kan Q, Ma S, Guan F and Sun T: Adipose-derived mesenchymal stem cells ameliorate acute liver injury in rat model of CLP induced-sepsis via sTNFR1. Exp Cell Res. 383:1114652019. View Article : Google Scholar : PubMed/NCBI

Umbro I, Gentile G, Tinti F, Muiesan P and Mitterhofer AP: Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury. J Infect. 72:131–142. 2016. View Article : Google Scholar

Gómez H and Kellum JA: Sepsis-induced acute kidney injury. Curr Opin Crit Care. 22:546–553. 2016. View Article : Google Scholar : PubMed/NCBI

Zarjou A and Agarwal A: Sepsis and acute kidney injury. J Am Soc Nephrol. 22:999–1006. 2011. View Article : Google Scholar : PubMed/NCBI

Yoshimoto K, Komaru Y, Iwagami M and Doi K: Acute kidney injury in sepsis: Evidence from Asia. Semin Nephrol. 40:489–497. 2020. View Article : Google Scholar : PubMed/NCBI

Manrique-Caballero CL, Del Rio-Pertuz G and Gomez H: Sepsis-associated acute kidney injury. Crit Care Clin. 37:279–301. 2021. View Article : Google Scholar : PubMed/NCBI

Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, Bagshaw SM, Glassford NJ, Lankadeva Y, Vaara ST and Schneider A: Acute kidney injury in sepsis. Intensive Care Med. 43:816–828. 2017. View Article : Google Scholar : PubMed/NCBI

Luo CJ, Zhang FJ, Zhang L, Geng YQ, Li QG, Hong Q, Fu B, Zhu F, Cui SY, Feng Z, et al: Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock. 41:123–129. 2014. View Article : Google Scholar

Cóndor JM, Rodrigues CE, Sousa Moreira RD, Canale D, Volpini RA, Shimizu MH, Camara NO, Noronha Ide L and Andrade L: Treatment with human Wharton's Jelly-derived mesenchymal stem cells attenuates sepsis-induced kidney injury, liver injury, and endothelial dysfunction. Stem Cells Transl Med. 5:1048–1057. 2016. View Article : Google Scholar : PubMed/NCBI

Chen CH, Cheng BC, Chen KH, Shao PL, Sung PH, Chiang HJ, Yang CC, Lin KC, Sun CK, Sheu JJ, et al: Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal stem cell preserved renal function in a chronic kidney disease and sepsis syndrome setting in rats. Oncotarget. 8:100002–100020. 2017. View Article : Google Scholar : PubMed/NCBI

Chen HH, Lin KC, Wallace CG, Chen YT, Yang CC, Leu S, Chen YC, Sun CK, Tsai TH, Chen YL, et al: Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury. J Pineal Res. 57:16–32. 2014. View Article : Google Scholar : PubMed/NCBI

Polito A, Eischwald F, Maho AL, Polito A, Azabou E, Annane D, Chrétien F, Stevens RD, Carlier R and Sharshar T: Pattern of brain injury in the acute setting of human septic shock. Crit Care. 17:R2042013. View Article : Google Scholar : PubMed/NCBI

Catarina AV, Branchini G, Bettoni L, De Oliveira JR and Nunes FB: Sepsis-associated encephalopathy: From pathophysiology to progress in experimental studies. Mol Neurobiol. 58:2770–2779. 2021. View Article : Google Scholar : PubMed/NCBI

Prescott HC and Angus DC: Enhancing recovery from sepsis: A review. JAMA. 319:62–75. 2018. View Article : Google Scholar : PubMed/NCBI

Oh SH, Choi C, Chang DJ, Shin DA, Lee N, Jeon I, Sung JH, Lee H, Hong KS, Ko JJ and Song J: Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells. Cytotherapy. 17:1090–1103. 2015. View Article : Google Scholar : PubMed/NCBI

Jiang W, Liang G, Li X, Li Z, Gao X, Feng S, Wang X, Liu M and Liu Y: Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAo. J Mater Sci Mater Med. 25:1357–1366. 2014. View Article : Google Scholar : PubMed/NCBI

Huang P, Gebhart N, Richelson E, Brott TG, Meschia JF and Zubair AC: Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation. Cytotherapy. 16:1336–1344. 2014. View Article : Google Scholar : PubMed/NCBI

Yoo SW, Chang DY, Lee HS, Kim GH, Park JS, Ryu BY, Joe EH, Lee YD, Kim SS and Suh-Kim H: Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-β. Neurobiol Dis. 58:249–257. 2013. View Article : Google Scholar : PubMed/NCBI

Redondo-Castro E, Cunningham C, Miller J, Martuscelli L, Aoulad-Ali S, Rothwell NJ, Kielty CM, Allan SM and Pinteaux E: Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res Ther. 8:792017. View Article : Google Scholar : PubMed/NCBI

Tan L, Cheng Y, Wang H, Tong J and Qin X: Peripheral transplantation of mesenchymal stem cells at sepsis convalescence improves cognitive function of sepsis surviving mice. Oxid Med Cell Longev. 2022:68977652022. View Article : Google Scholar : PubMed/NCBI

Silva AYO, Amorim ÉA, Barbosa-Silva MC, Lima MN, Oliveira HA, Granja MG, Oliveira KS, Fagundes PM, Neris RLS, Campos RMP, et al: Mesenchymal stromal cells protect the blood-brain barrier, reduce astrogliosis, and prevent cognitive and behavioral alterations in surviving septic mice. Crit Care Med. 48:e290–e298. 2020. View Article : Google Scholar : PubMed/NCBI

Li X, Zheng W, Bai H, Wang J, Wei R, Wen H and Ning H: Intravenous administration of adipose tissue-derived stem cells enhances nerve healing and promotes BDNF expression via the TrkB signaling in a rat stroke model. Neuropsychiatr Dis Treat. 12:1287–1293. 2016.PubMed/NCBI

Han C, Song L, Liu Y, Zou W, Jiang C and Liu J: Rat cortex and hippocampus-derived soluble factors for the induction of adipose-derived mesenchymal stem cells into neuron-like cells. Cell Biol Int. 38:768–776. 2014. View Article : Google Scholar : PubMed/NCBI

Gutiérrez-Fernández M, Rodriguez-Frutos B, Ramos-Cejudo J, Otero-Ortega L, Fuentes B, Vallejo-Cremades MT, Sanz-Cuesta BE and Díez-Tejedor E: Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: Proof of concept in rats. J Transl Med. 13:462015. View Article : Google Scholar : PubMed/NCBI

Ribeiro CA, Fraga JS, Grãos M, Neves NM, Reis RL, Gimble JM, Sousa N and Salgado AJ: The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res Ther. 3:182012. View Article : Google Scholar : PubMed/NCBI

Mahrouf-Yorgov M, Augeul L, Da Silva CC, Jourdan M, Rigolet M, Manin S, Ferrera R, Ovize M, Henry A, Guguin A, et al: Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties. Cell Death Differ. 24:1224–1238. 2017. View Article : Google Scholar : PubMed/NCBI

Liu J, Huang Y, He J, Zhuo Y, Chen W, Ge L, Duan D, Lu M and Hu Z: Olfactory mucosa mesenchymal stem cells ameliorate cerebral ischemic/reperfusion injury through modulation of UBIAD1 expression. Front Cell Neurosci. 14:5802062020. View Article : Google Scholar : PubMed/NCBI

Cao D, Qiao H, He D, Qin X, Zhang Q and Zhou Y: Mesenchymal stem cells inhibited the inflammation and oxidative stress in LPS-activated microglial cells through AMPK pathway. J Neural Transm (Vienna). 126:1589–1597. 2019. View Article : Google Scholar : PubMed/NCBI

Wang SS, Jia J and Wang Z: Mesenchymal stem cell-derived extracellular vesicles suppresses iNOS expression and ameliorates neural impairment in Alzheimer's disease mice. J Alzheimers Dis. 61:1005–1013. 2018. View Article : Google Scholar

Cai G, Cai G, Zhou H, Zhuang Z, Liu K, Pei S, Wang Y, Wang H, Wang X, Xu S, et al: Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction. Stem Cell Res Ther. 12:22021. View Article : Google Scholar : PubMed/NCBI

Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P, Allegranzi B and Reinhart K: Incidence and mortality of hospital- and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 46:1552–1562. 2020. View Article : Google Scholar : PubMed/NCBI

Aggarwal S and Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 105:1815–1822. 2005. View Article : Google Scholar

Li YP, Paczesny S, Lauret E, Poirault S, Bordigoni P, Mekhloufi F, Hequet O, Bertrand Y, Ou-Yang JP, Stoltz JF, et al: Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol. 180:1598–1608. 2008. View Article : Google Scholar : PubMed/NCBI

Chen X, Zhang Y, Wang W, Liu Z, Meng J and Han Z: Mesenchymal stem cells modified with heme oxygenase-1 have enhanced paracrine function and attenuate lipopolysaccharide-induced inflammatory and oxidative damage in pulmonary microvascular endothelial cells. Cell Physiol Biochem. 49:101–122. 2018. View Article : Google Scholar : PubMed/NCBI

Koliaraki V, Pallangyo CK, Greten FR and Kollias G: Mesenchymal cells in colon cancer. Gastroenterology. 152:964–979. 2017. View Article : Google Scholar : PubMed/NCBI

Parikh SM, Yang Y, He L, Tang C, Zhan M and Dong Z: Mitochondrial function and disturbances in the septic kidney. Semin Nephrol. 35:108–119. 2015. View Article : Google Scholar : PubMed/NCBI

Zheng K, Chen S and Hu X: Peroxisome proliferator-activated receptor gamma coactivator-1 alpha: A double-edged sword in prostate cancer. Curr Cancer Drug Targets. 22:541–559. 2022. View Article : Google Scholar : PubMed/NCBI

Zheng D, Zhou H, Wang H, Zhu Y, Wu Y, Li Q, Li T and Liu L: Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther. 12:2992021. View Article : Google Scholar : PubMed/NCBI

Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, Stolz DB, Watkins SC, Di YP, Leikauf GD, et al: Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 6:84722015. View Article : Google Scholar : PubMed/NCBI

Weber D, Hiergeist A, Weber M, Dettmer K, Wolff D, Hahn J, Herr W, Gessner A and Holler E: Detrimental effect of broad-spectrum antibiotics on intestinal microbiome diversity in patients after allogeneic stem cell transplantation: Lack of commensal sparing antibiotics. Clin Infect Dis. 68:1303–1310. 2019. View Article : Google Scholar

Valcz G, Krenács T, Sipos F, Leiszter K, Tóth K, Balogh Z, Csizmadia A, Muzes G, Molnár B and Tulassay Z: The role of the bone marrow derived mesenchymal stem cells in colonic epithelial regeneration. Pathol Oncol Res. 17:11–16. 2011. View Article : Google Scholar

Hayashi Y, Tsuji S, Tsujii M, Nishida T, Ishii S, Iijima H, Nakamura T, Eguchi H, Miyoshi E, Hayashi N and Kawano S: Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J Pharmacol Exp Ther. 326:523–531. 2008. View Article : Google Scholar : PubMed/NCBI

Nagashima K, Sawa S, Nitta T, Tsutsumi M, Okamura T, Penninger JM, Nakashima T and Takayanagi H: Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nat Immunol. 18:675–682. 2017. View Article : Google Scholar : PubMed/NCBI

Levi M: Current understanding of disseminated intravascular coagulation. Br J Haematol. 124:567–576. 2004. View Article : Google Scholar : PubMed/NCBI

Levi M, de Jonge E and van der Poll T: Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis. 16:43–47. 2003. View Article : Google Scholar

Semeraro N, Ammollo CT, Semeraro F and Colucci M: Coagulopathy of acute sepsis. Semin Thromb Hemost. 41:650–658. 2015. View Article : Google Scholar : PubMed/NCBI

Wang B, Wu S, Wang T, Ma Z and Liu K: Bone marrow-derived mesenchymal stem cells-mediated protection against organ dysfunction in disseminated intravascular coagulation is associated with peripheral immune responses. J Cell Biochem. 118:3184–3192. 2017. View Article : Google Scholar : PubMed/NCBI

Wang B, Wu SM, Wang T, Liu K, Zhang G, Zhang XQ, Yu JH, Liu CZ and Fang CC: Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model. Chin Med J (Engl). 125:1753–1759. 2012.PubMed/NCBI

Baudry N, Starck J, Aussel C, Lund K, Aletti M, Duranteau J, Banzet S, Lataillade JJ, Vicaut E and Peltzer J: Effect of preconditioned mesenchymal stromal cells on early microvascular disturbance in a mouse sepsis model. Stem Cells Dev. 28:1595–1606. 2019. View Article : Google Scholar : PubMed/NCBI

Ye Q, Qiu X, Wang J, Xu B, Su Y, Zheng C, Gui L, Yu L, Kuang H, Liu H, et al: MSCs-derived apoptotic extracellular vesicles promote muscle regeneration by inducing Pannexin 1 channel-dependent creatine release by myoblasts. Int J Oral Sci. 15:72023. View Article : Google Scholar : PubMed/NCBI

Sassoli C, Zecchi-Orlandini S and Formigli L: Trophic actions of bone marrow-derived mesenchymal stromal cells for muscle repair/regeneration. Cells. 1:832–850. 2012. View Article : Google Scholar : PubMed/NCBI

Gang EJ, Bosnakovski D, Simsek T, To K and Perlingeiro RCR: Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Exp Cell Res. 314:1721–1733. 2008. View Article : Google Scholar : PubMed/NCBI

Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, Takeda SI, Ide C and Nabeshima YI: Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science. 309:314–317. 2005. View Article : Google Scholar : PubMed/NCBI

Haghighipour N, Heidarian S, Shokrgozar MA and Amirizadeh N: Differential effects of cyclic uniaxial stretch on human mesenchymal stem cell into skeletal muscle cell. Cell Biol Int. 36:669–675. 2012. View Article : Google Scholar : PubMed/NCBI

Ninagawa NT, Isobe E, Hirayama Y, Murakami R, Komatsu K, Nagai M, Kobayashi M, Kawabata Y and Torihashi S: Transplantated mesenchymal stem cells derived from embryonic stem cells promote muscle regeneration and accelerate functional recovery of injured skeletal muscle. Biores Open Access. 2:295–306. 2013. View Article : Google Scholar : PubMed/NCBI

Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S and Yasunaga Y: Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng. 10:1093–1112. 2004. View Article : Google Scholar : PubMed/NCBI

Winkler T, von Roth P, Matziolis G, Mehta M, Perka C and Duda GN: Dose-response relationship of mesenchymal stem cell transplantation and functional regeneration after severe skeletal muscle injury in rats. Tissue Eng Part A. 15:487–492. 2009. View Article : Google Scholar

Winkler T, von Roth P, Radojewski P, Urbanski A, Hahn S, Preininger B, Duda GN and Perka C: Immediate and delayed transplantation of mesenchymal stem cells improve muscle force after skeletal muscle injury in rats. J Tissue Eng Regen Med. 6(Suppl 3): s60–s67. 2012. View Article : Google Scholar : PubMed/NCBI

von Roth P, Duda GN, Radojewski P, Preininger B, Perka C and Winkler T: Mesenchymal stem cell therapy following muscle trauma leads to improved muscular regeneration in both male and female rats. Gend Med. 9:129–136. 2012. View Article : Google Scholar : PubMed/NCBI

Meregalli M, Farini A, Belicchi M, Parolini D, Cassinelli L, Razini P, Sitzia C and Torrente Y: Perspectives of stem cell therapy in Duchenne muscular dystrophy. FEBS J. 280:4251–4262. 2013. View Article : Google Scholar

Jiang J, Yao P, Gu Y, Xu L, Xu J and Tan H: Adult rat mesenchymal stem cells delay denervated muscle atrophy. Cell Mol Neurobiol. 32:1287–1298. 2012. View Article : Google Scholar : PubMed/NCBI

Merritt EK, Cannon MV, Hammers DW, Le LN, Gokhale R, Sarathy A, Song TJ, Tierney MT, Suggs LJ, Walters TJ and Farrar RP: Repair of traumatic skeletal muscle injury with bone-marrow-derived mesenchymal stem cells seeded on extracellular matrix. Tissue Eng Part A. 16:2871–2881. 2010. View Article : Google Scholar : PubMed/NCBI

Stana F, Vujovic M, Mayaki D, Leduc-Gaudet JP, Leblanc P, Huck L and Hussain SNA: Differential regulation of the autophagy and proteasome pathways in skeletal muscles in sepsis. Crit Care Med. 45:e971–e979. 2017. View Article : Google Scholar : PubMed/NCBI

Khalil R: Ubiquitin-proteasome pathway and muscle atrophy. Adv Exp Med Biol. 1088:235–248. 2018. View Article : Google Scholar : PubMed/NCBI

Peruchi BB, Petronilho F, Rojas HA, Constantino L, Mina F, Vuolo F, Cardoso MR, Gonçalves CL, Rezin GT, Streck EL and Dal-Pizzol F: Skeletal muscle electron transport chain dysfunction after sepsis in rats. J Surg Res. 167:e333–e338. 2011. View Article : Google Scholar : PubMed/NCBI

Thoma A and Lightfoot AP: NF-kB and inflammatory cytokine signalling: Role in skeletal muscle atrophy. Adv Exp Med Biol. 1088:267–279. 2018. View Article : Google Scholar : PubMed/NCBI

Pelosi M, De Rossi M, Barberi L and Musarò A: IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activity. Biomed Res Int. 2014:2060262014. View Article : Google Scholar : PubMed/NCBI

Zhu S, Nagashima M, Khan MAS, Yasuhara S, Kaneki M and Martyn JAJ: Lack of caspase-3 attenuates immobilization-induced muscle atrophy and loss of tension generation along with mitigation of apoptosis and inflammation. Muscle Nerve. 47:711–721. 2013. View Article : Google Scholar : PubMed/NCBI

Okamura LH, Cordero P, Palomino J, Parraguez VH, Torres CG and Peralta OA: Myogenic differentiation potential of mesenchymal stem cells derived from fetal bovine bone marrow. Anim Biotechnol. 29:1–11. 2018. View Article : Google Scholar

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, et al: Bone marrow cells regenerate infarcted myocardium. Nature. 410:701–705. 2001. View Article : Google Scholar : PubMed/NCBI

Egusa H, Kobayashi M, Matsumoto T, Sasaki J, Uraguchi S and Yatani H: Application of cyclic strain for accelerated skeletal myogenic differentiation of mouse bone marrow-derived mesenchymal stromal cells with cell alignment. Tissue Eng Part A. 19:770–782. 2013. View Article : Google Scholar

Drost AC, Weng S, Feil G, Schäfer J, Baumann S, Kanz L, Sievert KD, Stenzl A and Möhle R: In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. Ann N Y Acad Sci. 1176:135–143. 2009. View Article : Google Scholar : PubMed/NCBI

Maeda Y, Yonemochi Y, Nakajyo Y, Hidaka H, Ikeda T and Ando Y: CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration. Sci Rep. 7:33052017. View Article : Google Scholar : PubMed/NCBI

Wakitani S, Saito T and Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 18:1417–1426. 1995. View Article : Google Scholar : PubMed/NCBI

Meligy FY, Shigemura K, Behnsawy HM, Fujisawa M, Kawabata M and Shirakawa T: The efficiency of in vitro isolation and myogenic differentiation of MSCs derived from adipose connective tissue, bone marrow, and skeletal muscle tissue. In Vitro Cell Dev Biol Anim. 48:203–215. 2012. View Article : Google Scholar : PubMed/NCBI

Asakura A: Stem cells in adult skeletal muscle. rends Cardiovasc Med. 13:123–128. 2003. View Article : Google Scholar

Dumont NA, Wang YX and Rudnicki MA: Intrinsic and extrinsic mechanisms regulating satellite cell function. Development. 142:1572–1581. 2015. View Article : Google Scholar : PubMed/NCBI

Thomas K, Engler AJ and Meyer GA: Extracellular matrix regulation in the muscle satellite cell niche. Connect Tissue Res. 56:1–8. 2015. View Article : Google Scholar :

Tonkin J, Temmerman L, Sampson RD, Gallego-Colon E, Barberi L, Bilbao D, Schneider MD, Musarò A and Rosenthal N: Monocyte/macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization. Mol Ther. 23:1189–1200. 2015. View Article : Google Scholar : PubMed/NCBI

Karp JM and Teo GSL: Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell. 4:206–216. 2009. View Article : Google Scholar : PubMed/NCBI

Zhou Q, Yang C and Yang P: The promotional effect of mesenchymal stem cell homing on bone tissue regeneration. Curr Stem Cell Res Ther. 12:365–376. 2017. View Article : Google Scholar

Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C and Sittinger M: Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem. 101:135–146. 2007. View Article : Google Scholar : PubMed/NCBI

Chen L, Li Y, Chen W, Han N, Li K, Guo R, Liu Z and Xiao Y: Enhanced recruitment and hematopoietic reconstitution of bone marrow-derived mesenchymal stem cells in bone marrow failure by the SDF-1/CXCR4. J Tissue Eng Regen Med. 14:1250–1260. 2020.PubMed/NCBI

Moll NM and Ransohoff RM: CXCL12 and CXCR4 in bone marrow physiology. Expert Rev Hematol. 3:315–322. 2010. View Article : Google Scholar : PubMed/NCBI

Pozzobon T, Goldoni G, Viola A and Molon B: CXCR4 signaling in health and disease. Immunol Lett. 177:6–15. 2016. View Article : Google Scholar : PubMed/NCBI

Mousavi A: CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy. Immunol Lett. 217:91–115. 2020. View Article : Google Scholar

Guo J, Zhang H, Xiao J, Wu J, Ye Y, Li Z, Zou Y and Li X: Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy. Int J Mol Sci. 14:8164–8178. 2013. View Article : Google Scholar : PubMed/NCBI

Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z, McCarthy PM and Penn MS: Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells. 25:245–251. 2007. View Article : Google Scholar

Ahn SY, Park WS, Kim YE, Sung DK, Sung SI, Ahn JY and Chang YS: Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury. Exp Mol Med. 50:1–12. 2018.

Shams S, Mohsin S, Nasir GA, Khan M and Khan SN: Mesenchymal stem cells pretreated with HGF and FGF4 can reduce liver fibrosis in mice. Stem Cells Int. 2015:7472452015. View Article : Google Scholar : PubMed/NCBI

Kumar S and Ponnazhagan S: Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. FASEB J. 21:3917–3927. 2007. View Article : Google Scholar : PubMed/NCBI

Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G and Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 279:1528–1530. 1998. View Article : Google Scholar : PubMed/NCBI

Winkler T, von Roth P, Schuman MR, Sieland K, Stoltenburg-Didinger G, Taupitz M, Perka C, Duda GN and Matziolis G: In vivo visualization of locally transplanted mesenchymal stem cells in the severely injured muscle in rats. Tissue Eng Part A. 14:1149–1160. 2008. View Article : Google Scholar : PubMed/NCBI

Le Blanc K and Mougiakakos D: Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 12:383–396. 2012. View Article : Google Scholar : PubMed/NCBI

da Justa Pinheiro CH, de Queiroz JC, Guimarães-Ferreira L, Vitzel KF, Nachbar RT, de Sousa LGO, de Souza AL Jr, Nunes MT and Curi R: Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Rev Rep. 8:363–374. 2012. View Article : Google Scholar

Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, et al: Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 15:42–49. 2009. View Article : Google Scholar

Chen L, Tredget EE, Wu PY and Wu Y: Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 3:e18862008. View Article : Google Scholar : PubMed/NCBI

Bencze M, Negroni E, Vallese D, Yacoub-Youssef H, Chaouch S, Wolff A, Aamiri A, Di Santo JP, Chazaud B, Butler-Browne G, et al: Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Mol Ther. 20:2168–2179. 2012. View Article : Google Scholar : PubMed/NCBI

Waterman RS, Tomchuck SL, Henkle SL and Betancourt AM: A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One. 5:e100882010. View Article : Google Scholar : PubMed/NCBI

de Couto G, Gallet R, Cambier L, Jaghatspanyan E, Makkar N, Dawkins JF, Berman BP and Marbán E: Exosomal MicroRNA transfer into macrophages mediates cellular postconditioning. Circulation. 136:200–214. 2017. View Article : Google Scholar : PubMed/NCBI

Xu R, Zhang F, Chai R, Zhou W, Hu M, Liu B, Chen X, Liu M, Xu Q, Liu N and Liu S: Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization. J Cell Mol Med. 23:7617–7631. 2019. View Article : Google Scholar : PubMed/NCBI

Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, Gao L, Xie J and Xu B: Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 115:1205–1216. 2019. View Article : Google Scholar : PubMed/NCBI

Simovic Markovic B, Gazdic M, Arsenijevic A, Jovicic N, Jeremic J, Djonov V, Arsenijevic N, Lukic ML and Volarevic V: Mesenchymal stem cells attenuate cisplatin-induced nephrotoxicity in iNOS-dependent manner. Stem Cells Int. 2017:13153782017. View Article : Google Scholar : PubMed/NCBI

Sassoli C, Pini A, Chellini F, Mazzanti B, Nistri S, Nosi D, Saccardi R, Quercioli F, Zecchi-Orlandini S and Formigli L: Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS One. 7:e375122012. View Article : Google Scholar : PubMed/NCBI

Murphy MB, Moncivais K and Caplan AI: Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 45:e542013. View Article : Google Scholar : PubMed/NCBI

Sassoli C, Frati A, Tani A, Anderloni G, Pierucci F, Matteini F, Chellini F, Zecchi Orlandini S, Formigli L and Meacci E: Mesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferation. PLoS One. 9:e1086622014. View Article : Google Scholar : PubMed/NCBI

Nakamura Y, Miyaki S, Ishitobi H, Matsuyama S, Nakasa T, Kamei N, Akimoto T, Higashi Y and Ochi M: Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett. 589:1257–1265. 2015. View Article : Google Scholar : PubMed/NCBI

Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, et al: Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest. 125:1215–1227. 2015. View Article : Google Scholar : PubMed/NCBI

Bizzarro V, Petrella A and Parente L: Annexin A1: Novel roles in skeletal muscle biology. J Cell Physiol. 227:3007–3015. 2012. View Article : Google Scholar : PubMed/NCBI

Kim S, Lee MJ, Choi JY, Park DH, Kwak HB, Moon S, Koh JW, Shin HK, Ryu JK, Park CS, et al: Roles of exosome-like vesicles released from inflammatory C2C12 myotubes: Regulation of myocyte differentiation and myokine expression. Cell Physiol Biochem. 48:1829–1842. 2018. View Article : Google Scholar : PubMed/NCBI

Choi JS, Yoon HI, Lee KS, Choi YC, Yang SH, Kim IS and Cho YW: Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and provide biochemical cues for skeletal muscle regeneration. J Control Release. 222:107–115. 2016. View Article : Google Scholar

Forterre A, Jalabert A, Berger E, Baudet M, Chikh K, Errazuriz E, De Larichaudy J, Chanon S, Weiss-Gayet M, Hesse AM, et al: Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: A new paradigm for myoblast-myotube cross talk? PLoS One. 9:e841532014. View Article : Google Scholar : PubMed/NCBI

Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M and Werner C: Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 22:377–384. 2004. View Article : Google Scholar : PubMed/NCBI

Wang C, Li Y, Yang M, Zou Y, Liu H, Liang Z, Yin Y, Niu G, Yan Z and Zhang B: Efficient differentiation of bone marrow mesenchymal stem cells into endothelial cells in vitro. Eur J Vasc Endovasc Surg. 55:257–265. 2018. View Article : Google Scholar

Lu W, Xiu X, Zhao Y and Gui M: Improved proliferation and differentiation of bone marrow mesenchymal stem cells into vascular endothelial cells with sphingosine 1-phosphate. Transplant Proc. 47:2035–2040. 2015. View Article : Google Scholar : PubMed/NCBI

Grote K, Petri M, Liu C, Jehn P, Spalthoff S, Kokemüller H, Luchtefeld M, Tschernig T, Krettek C, Haasper C and Jagodzinski M: Toll-like receptor 2/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors. Eur Cell Mater. 26:66–79. 2013. View Article : Google Scholar : PubMed/NCBI

Leroux L, Descamps B, Tojais NF, Séguy B, Oses P, Moreau C, Daret D, Ivanovic Z, Boiron JM, Lamazière JM, et al: Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther. 18:1545–1552. 2010. View Article : Google Scholar : PubMed/NCBI

Berebichez-Fridman R and Montero-Olvera PR: Sources and clinical applications of mesenchymal stem cells: State-of-the-art review. Sultan Qaboos Univ Med J. 18:e264–e277. 2018. View Article : Google Scholar

Mushahary D, Spittler A, Kasper C, Weber V and Charwat V: Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 93:19–31. 2018. View Article : Google Scholar

Spath L, Rotilio V, Alessandrini M, Gambara G, De Angelis L, Mancini M, Mitsiadis TA, Vivarelli E, Naro F, Filippini A and Papaccio G: Explant-derived human dental pulp stem cells enhance differentiation and proliferation potentials. J Cell Mol Med. 14:1635–1644. 2010. View Article : Google Scholar

Ueda N, Atsuta I, Ayukawa Y, Yamaza T, Furuhashi A, Narimatsu I, Matsuura Y, Kondo R, Watanabe Y, Zhang X and Koyano K: Novel application method for mesenchymal stem cell therapy utilizing its attractant-responsive accumulation property. Appl Sci. 9:49082019. View Article : Google Scholar

Castelo-Branco MTL, Soares IDO, Lopes DV, Buongusto F, Martinusso CA, do Rosario A Jr, Souza SA, Gutfilen B, Fonseca LM, Elia C, et al: Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One. 7:e333602012. View Article : Google Scholar : PubMed/NCBI

Gonçalves Fda C, Schneider N, Pinto FO, Meyer FS, Visioli F, Pfaffenseller B, Lopez PL, Passos EP, Cirne-Lima EO, Meurer L and Paz AH: Intravenous vs intraperitoneal mesenchymal stem cells administration: What is the best route for treating experimental colitis? World J Gastroenterol. 20:18228–18239. 2014. View Article : Google Scholar

Roux C, Saviane G, Pini J, Belaïd N, Dhib G, Voha C, Ibáñez L, Boutin A, Mazure NM, Wakkach A, et al: Immunosuppressive mesenchymal stromal cells derived from human-induced pluripotent stem cells induce human regulatory T cells in vitro and in vivo. Front Immunol. 8:19912018. View Article : Google Scholar : PubMed/NCBI

Braid LR, Wood CA, Wiese DM and Ford BN: Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes. Cytotherapy. 20:232–244. 2018. View Article : Google Scholar

Rangarajan A, Hong SJ, Gifford A and Weinberg RA: Erratum to species- and cell type-specific requirements for cellular transformation [Cancer Cell 6, (2004) 171-183]. Cancer Cell. 24:394–398. 2013. View Article : Google Scholar

Wang Y, Han ZB, Song YP and Han ZC: Safety of mesenchymal stem cells for clinical application. Stem Cells Int. 2012:6520342012. View Article : Google Scholar : PubMed/NCBI

Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, et al: Allogeneic human mesenchymal stem cell infusions for aging frailty. J Gerontol A Biol Sci Med Sci. 72:1505–1512. 2017. View Article : Google Scholar : PubMed/NCBI

Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, et al: Allogeneic mesenchymal stem cells ameliorate aging frailty: A phase II randomized, double-blind, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 72:1513–1522. 2017. View Article : Google Scholar : PubMed/NCBI

Kabat M, Bobkov I, Kumar S and Grumet M: Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range? Stem Cells Transl Med. 9:17–27. 2020. View Article : Google Scholar

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al: The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI

Mankowski RT, Laitano O, Darden D, Kelly L, Munley J, Loftus TJ, Mohr AM, Efron PA and Thomas RM: Sepsis-Induced myopathy and gut microbiome dysbiosis: Mechanistic links and therapeutic targets. Shock. 57:15–23. 2022. View Article : Google Scholar :

Liu Y, Wang D, Li T, Yang F, Li Z, Bai X and Wang Y: The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy. Front Immunol. 13:10357092022. View Article : Google Scholar : PubMed/NCBI

Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, Li L, Cao J, Xu F, Zhou Y, et al: Sepsis-induced immunosuppression: Mechanisms, diagnosis and current treatment options. Mil Med Res. 9:562022.PubMed/NCBI

Kramer CL: Intensive care unit-acquired weakness. Neurol Clin. 35:723–736. 2017. View Article : Google Scholar : PubMed/NCBI

Fu X, Liu G, Halim A, Ju Y, Luo Q and Song AG: Mesenchymal stem cell migration and tissue repair. Cells. 8:7842019. View Article : Google Scholar : PubMed/NCBI

Song J, Liu J, Cui C, Hu H, Zang N, Yang M, Yang J, Zou Y, Li J, Wang L, et al: Mesenchymal stromal cells ameliorate diabetes-induced muscle atrophy through exosomes by enhancing AMPK/ULK1-mediated autophagy. J Cachexia Sarcopenia Muscle. 14:915–929. 2023. View Article : Google Scholar : PubMed/NCBI

Abrigo J, Rivera JC, Aravena J, Cabrera D, Simon F, Ezquer F, Ezquer M and Cabello-Verrugio C: High fat diet-induced skeletal muscle wasting is decreased by mesenchymal stem cells administration: Implications on oxidative stress, ubiquitin proteasome pathway activation, and myonuclear apoptosis. Oxid Med Cell Longev. 2016:90478212016. View Article : Google Scholar : PubMed/NCBI